Sector Vaxcell-Bio Therapeutics Co., Ltd.
Stocks
A323990
KR7323990002
Biotechnology & Medical Research
|
End-of-day quote
Korea S.E.
2026-10-29
|
5-day change | 1st Jan Change | ||
| 3,790.00 KRW | -4.17% |
|
-10.72% | -62.06% |
| 09-20 | Vaxcell-Bio Therapeutics Co., Ltd.(KOSDAQ:A323990) dropped from S&P Global BMI Index | CI |
| 25-03-24 | Vaxcell-Bio Therapeutics Co., Ltd. completed the acquisition of ALBIOTEK Co., Ltd. | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.17% | -10.72% | -13.77% | -1.43% | -62.06% | -60.73% | -81.28% | -93.14% | - | 68.43M | |
| +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +105.71% | -14.63% | +243.04% | 53.03B | |
| -1.58% | -1.38% | +2.04% | +10.87% | +21.77% | +26.01% | +54.93% | +5.00% | +282.60% | 45.99B | |
| -0.89% | -3.06% | +1.45% | +13.25% | +21.98% | +17.70% | +98.58% | +3.59% | +1,014.85% | 42.45B | |
| +0.22% | +0.87% | -7.41% | +4.65% | +137.70% | +226.32% | +931.77% | +543.32% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| +0.30% | -1.49% | -10.38% | -4.97% | -7.21% | -14.53% | -5.27% | -68.31% | - | 22.1B | |
| +14.43% | +15.75% | -4.84% | +6.71% | -36.78% | -34.09% | +362.33% | +264.96% | +747.73% | 21.18B | |
| -1.23% | +4.54% | +9.89% | +16.87% | +21.72% | +16.95% | +182.73% | +201.76% | +2,255.72% | 19.38B | |
| +0.79% | +11.05% | +27.45% | +60.65% | +89.09% | +109.38% | +129.27% | -15.93% | +397.09% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -0.78% | +0.75% | +12.19% | +18.92% | +50.13% | +66.88% | +225.10% | +205.90% | +521.34% | 16.42B | |
| +0.70% | +3.40% | +10.16% | -0.32% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| +1.42% | +16.63% | +26.95% | +21.37% | +18.68% | +30.32% | -9.18% | -24.59% | +169.38% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.62% | +3.35% | +5.92% | +16.42% | +38.31% | +42.47% | +167.64% | +148.13% | +969.97% | 28.36B | |
| Weighted average by Cap. | +0.55% | +3.36% | +4.92% | +17.28% | +42.15% | +46.56% | +169.07% | +123.97% | +1,262.70% |
- Stock Market
- Stocks
- A323990 Stock
- Sector Vaxcell-Bio Therapeutics Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
